To sum up, our research suggested that CX3CL1 could promote invasion and migration of lung cancer A549 and H520 cells by up‐regulating the phosphorylation of cortactin, which might be a potential target of clinical diagnosis and therapy. This evidence concerns the gene CX3CL1 and lung carcinoma.